Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hodgkin Disease 3Lymphoma, Non-Hodgkin 2Leukemia 2Renal Pelvis and Ureter Urothelial Carcinoma 1Recurrence 1Pain 1Lymphoma, T-Cell 1Lymphoma 1Breast Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Specimen Handling 5Biopsy 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 3sodium-iodide symporter 2ruxolitinib 2duvelisib 2cemiplimab 2X-Rays 2Vincristine 2Prednisone 2Photons 2Immunoglobulin G 2Etoposide 2Doxorubicin 2Disulfides 2prednylidene 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Stem Cell Transplantation 1Standard of Care 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Nivolumab 1Melphalan 1Leukapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × pegfilgrastim × 30 days × Clear all
NCT07278856 2026-06-05

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

City of Hope Medical Center

Phase 1 Recruiting
20 enrolled
Lymphoid

Lymphoma, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡